Conditions Treated in Scottsdale

Conditions Treated with NeuroStar TMS Therapy in Scottsdale, AZ

When the volume of information about mental health conditions and treatment options feels overwhelming, it helps to focus on what has been clinically proven to work for your specific diagnosis. At The Schulte Institute in Scottsdale, AZ, we offer NeuroStar Advanced TMS Therapy — a non-invasive, FDA-cleared treatment that provides meaningful relief for patients whose symptoms have not responded adequately to traditional approaches like medication or psychotherapy. Below is an overview of the conditions we treat with NeuroStar TMS at our Scottsdale practice.

Treatment-Resistant Depression (MDD)

Treatment-resistant depression refers to a form of Major Depressive Disorder (MDD) that does not respond adequately to antidepressant medications — typically defined as failing to achieve meaningful improvement after two or more medication trials at appropriate doses and durations. If your depressive symptoms continue to impact your daily functioning, relationships, and quality of life despite medication and counseling, it can feel as though there are no options left. That is not the case.

NeuroStar TMS therapy at The Schulte Institute offers a clinically backed alternative for patients in Scottsdale with treatment-resistant depression. This FDA-cleared, non-invasive treatment uses focused magnetic pulses to target the specific brain regions responsible for mood control and emotional regulation. By reactivating dormant neural networks in the left dorsolateral prefrontal cortex — the area most commonly underactive in depression — TMS helps restore the brain’s natural capacity for emotional balance. In the largest real-world outcomes registry for TMS, 83% of patients experienced symptom relief and 62% achieved full remission (Sackeim et al., 2020). To learn more about whether you qualify, visit our Candidates page.

Anxious Depression

Anxious depression — sometimes called depression with comorbid anxiety — describes a clinical presentation in which a patient experiences both major depressive symptoms and significant anxiety simultaneously. Persistent worry, inability to break intrusive thought cycles, low motivation, and avoidance of previously enjoyed activities are all hallmarks of this challenging condition. Because the symptoms of both disorders are intertwined, anxious depression can be particularly difficult to manage with medication alone.

NeuroStar TMS is FDA-cleared to treat depressive episodes in adult patients with comorbid anxiety symptoms, making it a strong option for those in Scottsdale dealing with this presentation. Treatment at The Schulte Institute consists of 34 to 36 sessions delivered five days per week, each lasting between 20 and 45 minutes depending on your prescription dose. Committing to the full course of treatment is strongly recommended to achieve the most impactful and lasting results. To understand exactly what to expect session by session, visit our How It Works page.

Obsessive-Compulsive Disorder (OCD)

Obsessive-Compulsive Disorder is characterized by unwanted, intrusive thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) performed to relieve the anxiety those thoughts cause. When OCD is severe, it can significantly impair daily functioning, work performance, and personal relationships. While therapy and medication help many OCD patients, a substantial number continue to experience persistent symptoms that interfere with daily life.

NeuroStar TMS is FDA-cleared as an adjunct treatment for adult patients with OCD. At The Schulte Institute, our providers target the anterior cingulate cortex (ACC) and medial prefrontal cortex (mPFC) during OCD treatment — brain regions involved in emotional response regulation, decision-making, and error detection that are frequently dysregulated in individuals with OCD. By modulating activity in these circuits, TMS helps reduce the intensity and frequency of obsessions and compulsions. It is important to note that TMS is an adjunct therapy for OCD, meaning patients should continue any existing treatments — such as Cognitive Behavioral Therapy (CBT) with Exposure and Response Prevention (ERP) — alongside TMS. For a deeper look at how TMS works at the neurological level, visit our Why NeuroStar TMS page.

Off-Label TMS for Additional Conditions

Beyond its FDA-cleared indications, TMS is also supported by a growing body of clinical research for several other conditions. At The Schulte Institute, we offer off-label TMS for Generalized Anxiety Disorder (GAD), bipolar depression, and cognitive impairment associated with conditions such as Mild Cognitive Impairment (MCI) and Alzheimer’s disease. Off-label use means TMS is not yet FDA-approved for these specific conditions but is supported by peer-reviewed clinical evidence and physician expertise. Each patient is carefully evaluated before off-label TMS is recommended.

Please note that off-label TMS is generally not covered by insurance. A comprehensive evaluation is required prior to beginning any off-label treatment protocol. To learn more about each off-label application and the supporting research, visit our TMS Off-Label page. If you have questions about whether TMS — FDA-cleared or off-label — may be right for your specific condition, call (480) 941-9004 to speak with our Scottsdale team. We also offer Spravato (esketamine) nasal spray for treatment-resistant depression as a complementary advanced treatment option.

Frequently Asked Questions About Conditions Treated with TMS in Scottsdale